FDA product code QPF: Pediatric Autism Spectrum Disorder Diagnosis Aid

QPF is the FDA product code for pediatric autism spectrum disorder diagnosis aid. It is a Class II device, regulated under 21 CFR 882.1491 and reviewed by the Neurology panel. FDA has cleared 5 510(k) submissions under QPF, 5 in the last five years, from 3 different applicants. The average 510(k) review took 143 days (median 144); 138 days on average over the last three years. 1 De Novo request was granted under it.

Definition

A pediatric Autism Spectrum Disorder diagnosis aid is a prescription device that is intended for use as an aid in the diagnosis of Autism Spectrum Disorder in pediatric patients.

Classification

FieldValue
Device namePediatric Autism Spectrum Disorder Diagnosis Aid
Device classClass II
Regulation21 CFR 882.1491
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

510(k) clearances per year for QPF

YearClearancesAvg. review days
20221177
20231142
20252121
20261155

Compare with all 510(k) review times · Search every QPF clearance

Top QPF applicants

ApplicantClearancesLatest
Earlitec Diagnostics22026-03-05
Earlitec Diagnostics, Inc.22023-06-29
Cognoa, Inc.12025-04-11

Most recent QPF clearances

510(k)ApplicantDeviceDecision dateReview days
K253442Earlitec DiagnosticsEarliPoint Assessment2026-03-05155
K243558Cognoa, Inc.Canvas Dx2025-04-11144
K243891Earlitec DiagnosticsEarliPoint System2025-03-2698
K230337Earlitec Diagnostics, Inc.EarliPoint2023-06-29142
K213882Earlitec Diagnostics, Inc.EarliPoint System2022-06-08177

Recalls for QPF devices

openFDA lists no recalls for product code QPF.

Frequently asked questions

What is FDA product code QPF?

QPF is the FDA product code for pediatric autism spectrum disorder diagnosis aid. It is a Class II device, regulated under 21 CFR 882.1491 and reviewed by the Neurology panel.

What device class is QPF?

Class II, regulation 21 CFR 882.1491. Typical premarket route: 510(k).

How long does a 510(k) take for product code QPF?

Across 5 cleared submissions the average was 143 days from receipt to decision (median 144).

Which companies have the most QPF clearances?

Earlitec Diagnostics (2); Earlitec Diagnostics, Inc. (2); Cognoa, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times